Passage BIO, Inc. SEC filings PASG
Passage BIO, Inc. has 443 filings in SEC EDGAR's recent list, going back to Sep 6, 2019. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 6, 2026 | Nov 5, 2026 |
| EFFECT | Filing | Oct 9, 2026 | — |
| 424B3 | Prospectus | Oct 9, 2026 | — |
| S-4/A | Filing | Oct 8, 2026 | — |
| S-4/A | Filing | Oct 5, 2026 | — |
| S-4/A | Filing | Sep 21, 2026 | — |
| S-4/A | S-4a | Sep 3, 2026 | — |
| 425 | Filing | Sep 3, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 3, 2026 | Sep 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 425 | Filing | Jul 22, 2026 | — |
| S-4 | Registration for a merger or exchange | Jul 21, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Jul 2, 2026 | — |
| 4 | Insider transaction | Jun 29, 2026 | Jun 25, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 25, 2026 | — |
| 425 | Filing | Jun 24, 2026 | — |
| 425 | Filing | Jun 24, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure, Other events
|
Jun 24, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Agreement ended
|
May 27, 2026 | May 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Exit or restructuring costs
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2026 | Apr 20, 2026 |
| ARS | Annual report to shareholders | Apr 7, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 7, 2026 | — |
| DEF 14A | Proxy statement | Apr 7, 2026 | May 19, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Agreement ended
|
Mar 10, 2026 | Mar 4, 2026 |
| S-8 | Employee stock plan registration | Mar 4, 2026 | — |
| 10-K | Annual report | Mar 3, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 3, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 144 | Notice of proposed sale | Jan 9, 2026 | — |
| 4 | Insider transaction | Dec 29, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Dec 29, 2025 | Jan 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 18, 2025 | Sep 16, 2025 |
| 4 | Insider transaction | Sep 15, 2025 | Sep 11, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Other events
|
Jul 29, 2025 | Jul 28, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 24, 2025 | — |
| 144 | Notice of proposed sale | Jul 21, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 21, 2025 | — |
| 144 | Notice of proposed sale | Jul 15, 2025 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 14, 2025 | Jul 10, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 9, 2025 | — |
| 144 | Notice of proposed sale | Jul 7, 2025 | — |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 144 | Notice of proposed sale | Jun 24, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 23, 2025 | Jun 23, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2025 | May 28, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 13, 2025 | May 13, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 25, 2025 | — |
| 4 | Insider transaction | Apr 24, 2025 | Apr 24, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| ARS | Annual report to shareholders | Apr 16, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| DEF 14A | Proxy statement | Apr 16, 2025 | May 28, 2025 |
| 144 | Notice of proposed sale | Apr 15, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | May 28, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 15, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 15, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 15, 2025 |
| 424B5 | Prospectus supplement | Mar 5, 2025 | — |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 31, 2025 | Jan 29, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Impairment, Regulation FD disclosure, Other events
|
Jan 10, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 144 | Notice of proposed sale | Jan 6, 2025 | — |
| 4 | Insider transaction | Dec 31, 2024 | Dec 27, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 20, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 26, 2024 | — |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| 144 | Notice of proposed sale | Dec 4, 2024 | — |
| 144 | Notice of proposed sale | Dec 4, 2024 | — |
| 4 | Insider transaction | Nov 27, 2024 | Nov 25, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 24, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 3 | Initial insider ownership | Oct 2, 2024 | Sep 10, 2024 |
| 4 | Insider transaction | Sep 23, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Sep 18, 2024 | Sep 16, 2024 |
| 144 | Notice of proposed sale | Sep 16, 2024 | — |
| 144 | Notice of proposed sale | Sep 16, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 16, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Impairment
|
Sep 6, 2024 | Sep 4, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 9, 2024 | — |
| 3 | Initial insider ownership | Aug 9, 2024 | Aug 7, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 2, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 1, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 16, 2024 | Jul 16, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | May 29, 2024 | — |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2024 | May 21, 2024 |
| 424B3 | Prospectus | May 14, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2024 | May 14, 2024 |
| EFFECT | Filing | Apr 16, 2024 | — |
| CORRESP | Letter to the SEC | Apr 12, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Apr 12, 2024 | — |
| DEFA14A | Additional proxy material | Apr 9, 2024 | — |
| DEF 14A | Proxy statement | Apr 9, 2024 | May 24, 2024 |
| ARS | Annual report to shareholders | Apr 9, 2024 | Dec 31, 2023 |
| SC 13G | Ownership over 5% (passive) | Mar 29, 2024 | — |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| UPLOAD | Letter from the SEC | Mar 7, 2024 | — |
| S-8 | Employee stock plan registration | Mar 4, 2024 | — |
| S-3 | Shelf registration | Mar 4, 2024 | — |
| 10-K | Annual report | Mar 4, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Other events
|
Feb 29, 2024 | Feb 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 4 | Insider transaction | Feb 13, 2024 | Feb 10, 2024 |
| 4 | Insider transaction | Feb 13, 2024 | Aug 16, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2024 | Jan 5, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Jan 3, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Jan 3, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Dec 29, 2023 | Dec 27, 2023 |
| 8-K |
Current report
Other events
|
Dec 20, 2023 | Dec 20, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2023 | Nov 13, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 9, 2023 | — |
| 8-K |
Current report
Listing notice
|
Sep 1, 2023 | Aug 31, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Aug 7, 2023 | Aug 7, 2023 |
| 4 | Insider transaction | Aug 1, 2023 | Jul 28, 2023 |
| 4 | Insider transaction | Jul 31, 2023 | Jul 27, 2023 |
| 3 | Initial insider ownership | Jul 31, 2023 | Jul 28, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2023 | Jul 26, 2023 |
| 4 | Insider transaction | Jul 28, 2023 | Jul 28, 2023 |
| 3 | Initial insider ownership | Jul 28, 2023 | Jul 28, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 20, 2023 | Jul 15, 2023 |
| 4 | Insider transaction | Jun 29, 2023 | Jun 27, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 29, 2023 | — |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 15, 2023 | — |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2023 | May 11, 2023 |
| 4 | Insider transaction | Apr 20, 2023 | Apr 18, 2023 |
| ARS | Annual report to shareholders | Apr 14, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 14, 2023 | — |
| DEF 14A | Proxy statement | Apr 14, 2023 | May 25, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 6, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | Apr 5, 2023 | Mar 15, 2023 |
| 4 | Insider transaction | Apr 5, 2023 | Mar 15, 2023 |
| 4 | Insider transaction | Apr 5, 2023 | Mar 15, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PASG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1787297
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.